scholarly article | Q13442814 |
P356 | DOI | 10.1213/00000539-199311000-00028 |
P698 | PubMed publication ID | 8105723 |
P2093 | author name string | Kamiyama Y | |
Glass PS | |||
Hermann D | |||
Donn KH | |||
Grosse CM | |||
Hardman D | |||
Marton G | |||
Quill TJ | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pharmacokinetics | Q323936 |
opioid | Q427523 | ||
pharmacodynamics | Q725307 | ||
P304 | page(s) | 1031-1040 | |
P577 | publication date | 1993-11-01 | |
P1433 | published in | Anesthesia & Analgesia | Q72225 |
P1476 | title | Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). | |
P478 | volume | 77 |
Q36857602 | A cardiovascular monitoring system used in conscious cynomolgus monkeys for regulatory safety pharmacology. Part 2: Pharmacological validation. |
Q43639004 | A comparison of anaesthesia using remifentanil combined with either isoflurane, enflurane or propofol in patients undergoing gynaecological laparoscopy, varicose vein or arthroscopic surgery |
Q48629911 | A comparison of intubating conditions in children following induction of anaesthesia with propofol and suxamethonium or propofol and remifentanil |
Q51547521 | A comparison of propofol and remifentanil during monitored anesthesia care. |
Q36567110 | A comparison of the effects of fentanyl and remifentanil on nausea, vomiting, and pain after cesarean section |
Q48252077 | A double-blind randomised comparison of intravenous patient-controlled remifentanil with intramuscular pethidine for labour analgesia |
Q49061857 | A multicenter comparison of isoflurane and propofol as adjuncts to remifentanil-based anesthesia |
Q59470286 | Accidental administration of the remifentanil formulation Ultiva™ into the epidural space and the complete time course of its consequences: a case report |
Q30467484 | Accidental subcutaneous remifentanil infusion as a cause of delayed awakening after craniotomy |
Q37466427 | Anesthetic requirements and stress hormone responses in chronic spinal cord-injured patients undergoing surgery below the level of injury: nitrous oxide vs remifentanil |
Q46762491 | Antinociceptive effects of high-dose remifentanil in male methadone-maintained patients |
Q36284071 | Application of calibrated forceps for assessing mechanical nociception with high time resolution in mice |
Q41611523 | Assessment of operative risk for patients with advanced lung disease |
Q44700450 | Assessment of tracheal intubation in children after induction with propofol and different doses of remifentanil |
Q48263646 | Cardiovascular and respiratory safety pharmacology in Göttingen minipigs: Pharmacological characterization |
Q28305606 | Characterization of BU09059: a novel potent selective κ-receptor antagonist |
Q34006984 | Clinical and economic factors important to anaesthetic choice for day-case surgery |
Q36501060 | Closed-loop continuous infusions of etomidate and etomidate analogs in rats: a comparative study of dosing and the impact on adrenocortical function |
Q36364794 | Comparative Evaluation of Remifentanil and Dexmedetomidine in General Anesthesia for Cesarean Delivery |
Q42321275 | Comparison of dexmedetomidine and remifentanil for attenuation of hemodynamic responses to laryngoscopy and tracheal intubation |
Q34453779 | Comparison of intubating conditions with propofol suxamethonium versus propofol-LIDOCAINE. |
Q37041032 | Comparison of remifentanil and fentanyl for postoperative pain control after abdominal hysterectomy |
Q37289888 | Comparison of remifentanil and fentanyl regarding hemodynamic changes due to endotracheal intubation in preeclamptic parturient candidate for cesarean delivery. |
Q51429174 | Comparison of remifentanil with alfentanil or suxamethonium following propofol anaesthesia for tracheal intubation. |
Q39970860 | Comparison of remifentanil with dexmedetomidine for monitored anaesthesia care in elderly patients during vertebroplasty and kyphoplasty |
Q91632624 | Comparison of sedation between dexmedetomidine and propofol during transesophageal echocardiography: A randomized controlled trial |
Q36931290 | Comparison of target-controlled infusion of sufentanil and remifentanil in blunting hemodynamic response to tracheal intubation |
Q48168820 | Comparison of the antitussive effect of remifentanil during recovery from propofol and sevoflurane anaesthesia |
Q92696138 | Comparison of the efficacy and safety of remifentanil versus different pharmacological approaches on prevention of etomidate-induced myoclonus: a meta-analysis of randomized controlled trials |
Q39264120 | Comparison of the qCON and qNOX indices for the assessment of unconsciousness level and noxious stimulation response during surgery |
Q38091330 | Conscious sedation for awake fibreoptic intubation: a review of the literature |
Q40493012 | Dexmedetomidine decreases the requirement of ketamine and propofol during burns debridement and dressings |
Q35781786 | Dezocine Prevents Postoperative Hyperalgesia in Patients Undergoing Open Abdominal Surgery |
Q36709331 | Distinct Hypnotic Recoveries After Infusions of Methoxycarbonyl Etomidate and Cyclopropyl Methoxycarbonyl Metomidate: The Role of the Metabolite |
Q51429165 | Dosing study of remifentanil and propofol for tracheal intubation without the use of muscle relaxants. |
Q48308601 | Effect of divided supplementation of remifentanil on seizure duration and hemodynamic responses during electroconvulsive therapy under propofol anesthesia |
Q43148738 | Effect of remifentanil on cardiovascular and bispectral index responses following the induction of anesthesia with midazolam and subsequent tracheal intubation |
Q42393282 | Effect of remifentanil on consumption of sevoflurane in entropy monitored general anesthesia |
Q34428320 | Effect of remifentanil on mitochondrial oxygen consumption of cultured human hepatocytes |
Q36793150 | Effect-site concentration of remifentanil for minimizing cardiovascular changes by inhalation of desflurane. |
Q38373567 | Effect-site concentration of remifentanil required to blunt haemodynamic responses during tracheal intubation: A randomized comparison between single- and double-lumen tubes |
Q47636778 | Effects of changing from sevoflurane to desflurane on the recovery profile after sevoflurane induction: a randomized controlled study |
Q43687307 | Effects of combined methohexitone-remifentanil anaesthesia in electroconvulsive therapy |
Q37615074 | Efficacy and safety of remifentanil as an alternative labor analgesic |
Q47114406 | Efficacy and safety of remifentanil for analgesia in cesarean delivery |
Q41129077 | Electroencephalogram effects of armodafinil: comparison with behavioral alertness |
Q51532650 | Evaluating a possible pharmacokinetic interaction between remifentanil and esmolol in the rat. |
Q36929334 | Evaluation of propofol and remifentanil for intravenous sedation for reducing shoulder dislocations in the emergency department |
Q48269930 | Evaluation of recovery and anesthetic gas consumption using remifentanil combined with low-flow sevoflurane anesthesia in tympanoplasty |
Q36563400 | Experience with remifentanil in neonates and infants |
Q43725429 | Facilitation of laryngeal mask airway insertion: effects of remifentanil administered before induction with target-controlled propofol infusion |
Q95822261 | Factor V Leiden mutation and venous thrombosis |
Q39344672 | Fatal respiratory depression after multiple intravenous morphine injections |
Q36089544 | Hemodynamic effects of target-controlled infusion of propofol alone or in combination with a constant-rate infusion of remifentanil in dogs |
Q44546516 | High-dose remifentanil increases blood pressure and heart rate mediated by sympatho-activation in conscious rats |
Q33601084 | Importance of choice of drugs and timing of their administration |
Q44334103 | Initial Clinical Experience with Remifentanil, a New Opioid Metabolized by Esterases |
Q38213384 | Intraoperative use of remifentanil and opioid induced hyperalgesia/acute opioid tolerance: systematic review |
Q41032159 | Intravenous anaesthesia: new drugs, new concepts, and clinical applications |
Q35952797 | Inverted takotsubo-like left ventricular dysfunction with pulmonary oedema developed after caesarean delivery complicated by massive haemorrhage in a severe preeclamptic parturient with a prolonged painful labour |
Q44290269 | Learning about new anesthetics using a model driven, full human simulator |
Q35772677 | Low-dose remifentanil to modify hemodynamic responses to tracheal intubation: comparison in normotensive and untreated/treated hypertensive Korean patients |
Q48296870 | Middle-ear surgery under sedation: comparison of midazolam alone or midazolam with remifentanil |
Q51596164 | Modern opioids: uses defined by chrono-pharmacology, not receptor selectivity. |
Q33881417 | Natural inhibitors of cholinesterases: implications for adverse drug reactions. |
Q33542933 | Neuroleptanesthesia: current status |
Q39259310 | Obstetric analgesia in German clinics. Remifentanil as alternative to regional analgesia |
Q88926746 | Optimal effect-site concentration of remifentanil for minimizing cardiovascular changes caused by fiberoptic nasotracheal intubation |
Q37205670 | Optimal effect-site concentration of remifentanil for preventing cough during removal of the double-lumen endotracheal tube from sevoflurane-remifentanil anesthesia: A prospective clinical trial |
Q37589421 | Optimal effect-site concentration of remifentanil when combined with dexmedetomidine in patients undergoing cystoscopy |
Q58595082 | Optimal effective-site concentration of remifentanil for sedation during plate removal of maxilla |
Q88553469 | Optimal neuromuscular blocking effects of remifentanil during tracheal intubation under general anesthesia |
Q33997068 | Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans |
Q58817152 | Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans |
Q73506602 | Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans |
Q47926093 | Pain control in patients with hepatocellular carcinoma treated by percutaneous radiofrequency ablation: comparison of the efficacy of one-shot and continuous intravenous fentanyl delivery |
Q39208678 | Patient-Controlled Remifentanil Analgesia as Alternative for Pethidine with Midazolam During Oocyte Retrieval in IVF/ICSI Procedures: A Randomized Controlled Trial |
Q39206124 | Patient-controlled analgesia after coronary bypass: Remifentanil or sufentanil? |
Q36688895 | Patient-controlled analgesia in the management of postoperative pain |
Q24187501 | Patient-controlled analgesia with remifentanil versus alternative parenteral methods for pain management in labour |
Q46884282 | Patient-controlled intravenous analgesia with remifentanil in nulliparous subjects in labor |
Q38983589 | Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review. |
Q27025071 | Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. a minireview |
Q37313355 | Pharmacokinetics of Remifentanil: a three-compartmental modeling approach |
Q33714237 | Pharmacokinetics of opioids in liver disease |
Q39460590 | Pharmacokinetics of opioids in renal dysfunction |
Q34401942 | Pharmacotherapy of opioids: present and future developments |
Q47152342 | Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation. |
Q33487458 | Population pharmacokinetics of remifentanil in infants and children undergoing cardiac surgery |
Q38233119 | Pre-operative anesthetic assessment of patients with rheumatoid arthritis |
Q37533872 | Randomized double-blind comparison of remifentanil and alfentanil in patients undergoing laparoscopic cholecystectomy using total intravenous anesthesia |
Q39868519 | Rat cardiovascular telemetry: Marginal distribution applied to positive control drugs |
Q56482381 | Remifentanil |
Q36417154 | Remifentanil : a review of its analgesic and sedative use in the intensive care unit |
Q48317752 | Remifentanil Decreases Sevoflurane Requirements to Block Autonomic Hyperreflexia During Transurethral Litholapaxy in Patients with High Complete Spinal Cord Injury |
Q48320956 | Remifentanil and propofol for weaning of mechanically ventilated pediatric intensive care patients. |
Q43901054 | Remifentanil and the tunnelling phase of paediatric ventriculoperitoneal shunt insertion. A double-blind, randomised, prospective study |
Q37727505 | Remifentanil at induction of general anesthesia for cesarean section: Double blind,randomized clinical trial |
Q46834785 | Remifentanil decreases sevoflurane requirements in children |
Q39234882 | Remifentanil for labour analgesia: a double-blinded, randomised controlled trial of maternal and neonatal effects of patient-controlled analgesia versus continuous infusion |
Q48101166 | Remifentanil for labour analgesia: time to draw breath? |
Q38715407 | Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials |
Q43958805 | Remifentanil infusion for cardiac catheterization in children with congenital heart disease |
Q48578804 | Remifentanil patient-controlled analgesia for labour: optimizing drug delivery regimens |
Q40431002 | Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal |
Q51535041 | Remifentanil versus alfentanil in a balanced anesthetic technique for total abdominal hysterectomy. |
Q51098587 | Remifentanil versus propofol as adjuncts to regional anesthesia. Remifentanil 3010 Study Group. |
Q51492483 | Remifentanil, fentanyl, and alfentanil have no influence on the respiratory burst of human neutrophils in vitro. |
Q34798389 | Remifentanil, fentanyl, or the combination in surgical procedures in the United States: predictors of use in patients with organ impairment or obesity |
Q34162115 | Remifentanil-propofol sedation as an ambulatory anesthesia for carpal tunnel release |
Q36237539 | Remifentanil: a review of its use during the induction and maintenance of general anaesthesia |
Q40279535 | Remifentanil: an esterase-metabolized opioid |
Q36160713 | Review of the efficacy and safety of remifentanil for the prevention and treatment of pain during and after procedures and surgery. |
Q44360863 | Sedation for outpatient endometrial biopsy: comparison of remifentanil-propofol and alfentanil-propofol |
Q44228233 | Simultaneous solid-phase extraction combined with liquid chromatography with ultraviolet absorbance detection for the determination of remifentanil and its metabolite in dog plasma |
Q40876694 | Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients. |
Q58129216 | Solid-Phase Extraction Combined with UHPLC-MS/MS Method for Determination of Remifentanil in Human Whole Blood |
Q36332688 | Spotlight on remifentanil for general anaesthesia |
Q39350731 | Spotlight on remifentanil: its analgesic and sedative use in the intensive care unit |
Q36354679 | The EC(50) of remifentanil to minimize the cardiovascular changes during head holder pinning in neurosurgery |
Q43070579 | The clinical pharmacology of remifentanil: a brief review |
Q35772667 | The effect of dexmedetomidine on the adjuvant propofol requirement and intraoperative hemodynamics during remifentanil-based anesthesia |
Q34459221 | The effects of remifentanil on epileptiform discharges during intraoperative electrocorticography in patients undergoing epilepsy surgery |
Q36354662 | The median effective effect-site concentration of remifentanil for minimizing the cardiovascular changes to endotracheal intubation during desflurane anesthesia in pediatric patients |
Q51530920 | The pharmacokinetics and electroencephalogram response of remifentanil alone and in combination with esmolol in the rat. |
Q41292133 | The pharmacokinetics of remifentanil |
Q35196796 | The proper effect site concentration of remifentanil for prevention of myoclonus after etomidate injection |
Q41969457 | The use of alfaxalone and remifentanil total intravenous anesthesia in a dog undergoing a craniectomy for tumor resection. |
Q48582646 | The use of propofol and remifentanil for the anaesthetic management of a super-obese patient |
Q80474148 | The use of remifentanil infusion to facilitate epidural catheter placement in a parturient: a case report with pharmacokinetic simulations |
Q36200174 | The use of ultra-short-acting opioids in paediatric anaesthesia: the role of remifentanil |
Q51488547 | Tracheal intubation without neuromuscular blockade in children: a comparison of propofol combined either with alfentanil or remifentanil. |
Q51407859 | Tracheal intubation without the use of muscle relaxants: remifentanil or alfentanil in combination with propofol. |
Q39361594 | Use of remifentanil for tracheal intubation for caesarean section in a patient with suxamethonium apnoea |
Q51501516 | Use of remifentanil in infants. |
Q44696082 | Using fMRI to quantify the time dependence of remifentanil analgesia in the human brain |
Q73525835 | [Esters and stereoisomers] |
Search more.